Logo image of PRLB

PROTO LABS INC (PRLB) Stock Fundamental Analysis

USA - NYSE:PRLB - US7437131094 - Common Stock

50.55 USD
-0.34 (-0.67%)
Last: 9/19/2025, 8:04:00 PM
50.55 USD
0 (0%)
After Hours: 9/19/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, PRLB scores 4 out of 10 in our fundamental rating. PRLB was compared to 128 industry peers in the Machinery industry. While PRLB has a great health rating, there are worries on its profitability. PRLB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

PRLB had positive earnings in the past year.
In the past year PRLB had a positive cash flow from operations.
PRLB had positive earnings in 4 of the past 5 years.
In the past 5 years PRLB always reported a positive cash flow from operatings.
PRLB Yearly Net Income VS EBIT VS OCF VS FCFPRLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

With a Return On Assets value of 1.99%, PRLB is not doing good in the industry: 60.94% of the companies in the same industry are doing better.
The Return On Equity of PRLB (2.23%) is worse than 65.63% of its industry peers.
PRLB has a Return On Invested Capital of 2.11%. This is in the lower half of the industry: PRLB underperforms 67.97% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PRLB is significantly below the industry average of 10.02%.
Industry RankSector Rank
ROA 1.99%
ROE 2.23%
ROIC 2.11%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
PRLB Yearly ROA, ROE, ROICPRLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With a Profit Margin value of 2.91%, PRLB is not doing good in the industry: 60.16% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of PRLB has declined.
PRLB's Operating Margin of 4.38% is on the low side compared to the rest of the industry. PRLB is outperformed by 64.84% of its industry peers.
PRLB's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 44.17%, PRLB belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
PRLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.38%
PM (TTM) 2.91%
GM 44.17%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
PRLB Yearly Profit, Operating, Gross MarginsPRLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PRLB is destroying value.
Compared to 1 year ago, PRLB has less shares outstanding
PRLB has less shares outstanding than it did 5 years ago.
PRLB has a better debt/assets ratio than last year.
PRLB Yearly Shares OutstandingPRLB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
PRLB Yearly Total Debt VS Total AssetsPRLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

PRLB has an Altman-Z score of 10.74. This indicates that PRLB is financially healthy and has little risk of bankruptcy at the moment.
PRLB's Altman-Z score of 10.74 is amongst the best of the industry. PRLB outperforms 92.97% of its industry peers.
The Debt to FCF ratio of PRLB is 0.01, which is an excellent value as it means it would take PRLB, only 0.01 years of fcf income to pay off all of its debts.
PRLB has a Debt to FCF ratio of 0.01. This is amongst the best in the industry. PRLB outperforms 93.75% of its industry peers.
PRLB has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
PRLB has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. PRLB outperforms 88.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 10.74
ROIC/WACC0.21
WACC10.01%
PRLB Yearly LT Debt VS Equity VS FCFPRLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.31 indicates that PRLB has no problem at all paying its short term obligations.
PRLB has a better Current ratio (3.31) than 79.69% of its industry peers.
PRLB has a Quick Ratio of 3.09. This indicates that PRLB is financially healthy and has no problem in meeting its short term obligations.
PRLB has a Quick ratio of 3.09. This is amongst the best in the industry. PRLB outperforms 90.63% of its industry peers.
Industry RankSector Rank
Current Ratio 3.31
Quick Ratio 3.09
PRLB Yearly Current Assets VS Current LiabilitesPRLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

The earnings per share for PRLB have decreased by -9.14% in the last year.
Measured over the past years, PRLB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.19% on average per year.
Looking at the last year, PRLB shows a decrease in Revenue. The Revenue has decreased by -0.12% in the last year.
The Revenue has been growing slightly by 1.78% on average over the past years.
EPS 1Y (TTM)-9.14%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%7.89%
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%7.51%

3.2 Future

The Earnings Per Share is expected to grow by 0.06% on average over the next years.
PRLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.88% yearly.
EPS Next Y-9.01%
EPS Next 2Y0.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.01%
Revenue Next 2Y4.88%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PRLB Yearly Revenue VS EstimatesPRLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PRLB Yearly EPS VS EstimatesPRLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.79, the valuation of PRLB can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of PRLB indicates a slightly more expensive valuation: PRLB is more expensive than 62.50% of the companies listed in the same industry.
PRLB is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 30.97 indicates a quite expensive valuation of PRLB.
PRLB's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. PRLB is more expensive than 67.19% of the companies in the same industry.
PRLB is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.86, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 31.79
Fwd PE 30.97
PRLB Price Earnings VS Forward Price EarningsPRLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PRLB is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, PRLB is valued a bit cheaper than the industry average as 73.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.31
EV/EBITDA 19.19
PRLB Per share dataPRLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.06%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PRLB!.
Industry RankSector Rank
Dividend Yield N/A

PROTO LABS INC

NYSE:PRLB (9/19/2025, 8:04:00 PM)

After market: 50.55 0 (0%)

50.55

-0.34 (-0.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners93.84%
Inst Owner Change-1.46%
Ins Owners1.05%
Ins Owner Change1.82%
Market Cap1.21B
Analysts78.18
Price Target51 (0.89%)
Short Float %2.89%
Short Ratio3.81
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.34%
Min EPS beat(2)10.87%
Max EPS beat(2)17.81%
EPS beat(4)4
Avg EPS beat(4)22.12%
Min EPS beat(4)10.87%
Max EPS beat(4)43.37%
EPS beat(8)8
Avg EPS beat(8)29.73%
EPS beat(12)11
Avg EPS beat(12)24.46%
EPS beat(16)14
Avg EPS beat(16)22.81%
Revenue beat(2)2
Avg Revenue beat(2)1.71%
Min Revenue beat(2)0.02%
Max Revenue beat(2)3.41%
Revenue beat(4)3
Avg Revenue beat(4)1.07%
Min Revenue beat(4)-0.63%
Max Revenue beat(4)3.41%
Revenue beat(8)5
Avg Revenue beat(8)0.83%
Revenue beat(12)7
Avg Revenue beat(12)0.53%
Revenue beat(16)8
Avg Revenue beat(16)0.22%
PT rev (1m)0%
PT rev (3m)11.11%
EPS NQ rev (1m)2.62%
EPS NQ rev (3m)-2.91%
EPS NY rev (1m)6.21%
EPS NY rev (3m)6.21%
Revenue NQ rev (1m)0.8%
Revenue NQ rev (3m)3.15%
Revenue NY rev (1m)2.48%
Revenue NY rev (3m)2.61%
Valuation
Industry RankSector Rank
PE 31.79
Fwd PE 30.97
P/S 2.37
P/FCF 18.31
P/OCF 16.99
P/B 1.82
P/tB 3.26
EV/EBITDA 19.19
EPS(TTM)1.59
EY3.15%
EPS(NY)1.63
Fwd EY3.23%
FCF(TTM)2.76
FCFY5.46%
OCF(TTM)2.97
OCFY5.89%
SpS21.31
BVpS27.85
TBVpS15.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.99%
ROE 2.23%
ROCE 3.27%
ROIC 2.11%
ROICexc 2.48%
ROICexgc 5.07%
OM 4.38%
PM (TTM) 2.91%
GM 44.17%
FCFM 12.96%
ROA(3y)-2.81%
ROA(5y)0.4%
ROE(3y)-3.29%
ROE(5y)0.41%
ROIC(3y)2.43%
ROIC(5y)3.16%
ROICexc(3y)2.8%
ROICexc(5y)3.78%
ROICexgc(3y)5.45%
ROICexgc(5y)6.71%
ROCE(3y)3.77%
ROCE(5y)4.91%
ROICexcg growth 3Y-8.13%
ROICexcg growth 5Y-18.97%
ROICexc growth 3Y-4.98%
ROICexc growth 5Y-24.03%
OM growth 3Y-14.89%
OM growth 5Y-21.81%
PM growth 3Y-21.48%
PM growth 5Y-24.92%
GM growth 3Y-0.78%
GM growth 5Y-2.78%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 14.62%
Cap/Sales 1.01%
Interest Coverage 250
Cash Conversion 123.98%
Profit Quality 444.91%
Current Ratio 3.31
Quick Ratio 3.09
Altman-Z 10.74
F-Score6
WACC10.01%
ROIC/WACC0.21
Cap/Depr(3y)51.87%
Cap/Depr(5y)76.84%
Cap/Sales(3y)3.95%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.14%
EPS 3Y1.69%
EPS 5Y-10.19%
EPS Q2Q%7.89%
EPS Next Y-9.01%
EPS Next 2Y0.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.12%
Revenue growth 3Y0.87%
Revenue growth 5Y1.78%
Sales Q2Q%7.51%
Revenue Next Year5.01%
Revenue Next 2Y4.88%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.61%
EBIT growth 3Y-14.15%
EBIT growth 5Y-20.42%
EBIT Next Year58.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.71%
FCF growth 3Y48.42%
FCF growth 5Y4.96%
OCF growth 1Y12.72%
OCF growth 3Y12.13%
OCF growth 5Y-7.69%